AI Earnings Predictions for Embecta Corp. (EMBC)

EX-99.1

2 q32026ex-991.htm

EX-99.1

Document

FOR IMMEDIATE RELEASE

Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

PARSIPPANY, N.J., Aug 7, 2026 (GLOBE NEWSWIRE) – Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine month periods ended June 30, 2026.

"Our third quarter results improved significantly on a sequential basis, with revenue increasing approximately $50 million, GAAP operating income increasing approximately $14 million, and adjusted operating income increasing approximately $21 million as compared to our second quarter results. The sequential increase was due to a combination of factors, including improved performance within the United States and International, as well as contribution from the acquisition of Owen Mumford which closed mid-way through our third quarter," said Devdatt (Dev) Kurdikar, Chairman, President and Chief Executive Officer of embecta.

Mr. Kurdikar continued, "We repaid approximately $53 million of debt during the quarter and also repurchased approximately $9 million of shares under our three-year, up to $100 million share repurchase program. While our GLP-1 B2B partners launched generic GLP-1 therapies co-packaged with our pen needles in Canada and Brazil."

Mr. Kurdikar concluded, "Given our year-to-date performance, we are reaffirming our fiscal year revenue guidance range and raising our full year guidance ranges for adjusted operating margin and adjusted earnings per share."

Third Quarter Fiscal Year 2026 Financial Highlights:

•Reported revenues of $271.7 million, down 8.1% on a reported basis; down 8.9% on an adjusted constant currency basis

◦U.S. revenues decreased 24.6% on both a reported and adjusted constant currency basis

◦International revenues increased 11.5% on a reported basis, and 9.7% on an adjusted constant currency basis

•Gross profit and margin of $153.3 million and 56.4%, compared to $197.1 million and 66.7% in the prior year period

•Adjusted gross profit and margin of $158.0 million and 58.2%, compared to $198.6 million and 67.2% in the prior year period

•Operating income and margin of $48.7 million and 17.9%, compared to $94.0 million and 31.8% in the prior year period

•Adjusted operating income and margin of $69.4 million and 25.5%, compared to $109.1 million and 36.9% in the prior year period

•Net income and earnings per diluted share of $21.1 million and $0.36, compared to $45.5 million and $0.78 in the prior year period

•Adjusted net income and adjusted earnings per diluted share of $32.6 million and $0.56, compared to $65.5 million and $1.12 in the prior year period

•Adjusted EBITDA and margin of $85.7 million and 31.5%, compared to $131.0 million and 44.3% in the prior year period

•Announced a dividend of $0.01 per share

1

Nine Months Ended June 30 2026 Financial Highlights:

•Reported revenues of $754.7 million, down 7.6% on a reported basis; down 9.4% on an adjusted constant currency basis

◦U.S. revenues decreased 20.6% on both a reported and adjusted constant currency basis

◦International revenues increased 7.5% on a reported basis, and 3.6% on an adjusted constant currency basis

•Gross profit and margin of $442.8 million and 58.7%, compared to $518.3 million and 63.5% in the prior year period

•Adjusted gross profit and margin of $453.4 million and 60.1%, compared to $527.8 million and 64.6% in the prior year period

•Operating income and margin of $167.0 million and 22.1%, compared to $185.6 million and 22.7% in the prior year period

•Adjusted operating income and margin of $197.3 million and 26.1%, compared to $271.0 million and 33.2% in the prior year period

•Net income and earnings per diluted share of $61.1 million and $1.03, compared to $69.0 million and $1.18 in the prior year period

•Adjusted net income and adjusted earnings per diluted share of $91.0 million and $1.53, compared to $144.5 million and $2.46 in the prior year period

•Adjusted EBITDA and margin of $247.5 million and 32.8%, compared to $325.4 million and 39.9% in the prior year period

Strategic Highlights:

•Strengthen core business

◦Market-appropriate pen needles are progressing through regulatory review with the U.S. FDA and BSI for CE Mark certification

◦Market-appropriate syringe launches in certain geographies expected in the coming months

◦Completed brand transition in key European, Asian and Latin American markets and remain on track to be substantially complete by end of calendar year 2026

•Expand product portfolio

◦Completed the acquisition of Owen Mumford Holdings Limited ("Owen Mumford"); integration is progressing as planned

◦Continued to build on commercial momentum with the expansion of our B2B co-packaging opportunity, as generic GLP-1 therapies featuring embecta pen needles in the commercial packaging launched in Canada and Brazil, following the initial launch in India

◦Expect launch of GLP-1 small pack format in

SEC.gov | Request Rate Threshold Exceeded

U.S. Securities and Exchange Commission

You’ve Exceeded the SEC’s Traffic Limit

Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.

Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.

The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.

For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.

For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.

Reference ID: 0.c706d217.1784725707.36140326

More Information

Internet Security Policy

By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.

Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).

To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.

If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.

Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.

Note: We do not offer technical support for developing or debugging scripted downloading processes.

embc-202602050001872789FALSE00018727892026-02-052026-02-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2026

EMBECTA CORP.

(Exact name of registrant as specified in its charter)

Delaware (State or Other Jurisdiction of Incorporation)

001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)

300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each classTrading symbol(s) Name of each exchange on which registered

Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.Results of Operations and Financial Condition. On February 5, 2026, Embecta Corp. issued a press release (the “Press Release”) regarding its results for the quarter ended December 31, 2025. The Press Release is furnished as Exhibit 99.1 to this report.

Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:

99.1 Press Release, dated February 5, 2026.

104Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EMBECTA CORP.

Dated: February 5, 2026 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer